Ultimately, irreparable DNA damage in tumor cells induced by RT increases tumor immunogenicity by providing dendritic cells with tumor-specific antigens to present to, and activate, CD8+ T cells via major histocompatibility complex (MHC) class 1. The gene discussed is CD8A; the disease is neoplasm.